| 000 | 01876 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515145659.0 | ||
| 264 | 0 | _c20090710 | |
| 008 | 200907s 0 0 eng d | ||
| 022 | _a1573-2568 | ||
| 024 | 7 |
_a10.1007/s10620-008-0545-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTougeron, David | |
| 245 | 0 | 0 |
_aPredicting factors of fistula healing and clinical remission after infliximab-based combined therapy for perianal fistulizing Crohn's disease. _h[electronic resource] |
| 260 |
_bDigestive diseases and sciences _cAug 2009 |
||
| 300 |
_a1746-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAzathioprine _xtherapeutic use |
| 650 | 0 | 4 |
_aCiprofloxacin _xtherapeutic use |
| 650 | 0 | 4 |
_aCrohn Disease _xdrug therapy |
| 650 | 0 | 4 | _aDrainage |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 |
_aIntestinal Fistula _xdrug therapy |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
| 650 | 0 | 4 |
_aMetronidazole _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRetrospective Studies |
| 700 | 1 | _aSavoye, Guillaume | |
| 700 | 1 | _aSavoye-Collet, Céline | |
| 700 | 1 | _aKoning, Edith | |
| 700 | 1 | _aMichot, Francis | |
| 700 | 1 | _aLerebours, Eric | |
| 773 | 0 |
_tDigestive diseases and sciences _gvol. 54 _gno. 8 _gp. 1746-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10620-008-0545-y _zAvailable from publisher's website |
| 999 |
_c18461359 _d18461359 |
||